Targeting the HIV trans-activation responsive region--approaches towards RNA-binding drugs.
Krebs
Andreas
A
Institute for Organic Chemistry and Chemical Biology, Goethe University, Frankfurt, Marie-Curie Strasse 11, 60439 Frankfurt am Main.
Ludwig
Verena
V
Boden
Oliver
O
Göbel
Michael W
MW
D000166:Acridines / Q000494:pharmacology; D000617:Aminoglycosides / Q000737:chemistry / Q000494:pharmacology; D001562:Benzimidazoles / Q000494:pharmacology; D001665:Binding Sites; D016503:Drug Delivery Systems / Q000639:trends*; D015195:Drug Design; D015696:Gene Products, tat / Q000737:chemistry / Q000187:drug effects* / Q000235:genetics; D016325:HIV Long Terminal Repeat / Q000187:drug effects* / Q000235:genetics; D006367:HeLa Cells / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D008024:Ligands; D008958:Models, Molecular; D010455:Peptides / Q000737:chemistry / Q000494:pharmacology; D011810:Quinoxalines / Q000494:pharmacology; D012313:RNA / Q000737:chemistry / Q000378:metabolism; D013678:Technology, Pharmaceutical / Q000639:trends*
D000166:Acridines; D000617:Aminoglycosides; D001562:Benzimidazoles; C120944:CPG 40336A; D015696:Gene Products, tat; D008024:Ligands; D010455:Peptides; D011810:Quinoxalines; C447680:hoechst 32258; D012313:RNA